Cardlytics, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
CDLX
Cardlytics, INCThe Vanguard Group has filed an amendment to its Schedule 13G, disclosing a 4.60% beneficial ownership stake in Cardlytics Inc. as of June 30, 2025.
NASDAQ
CDLX
Cardlytics, INCBlackRock, Inc. has filed an Amendment No. 6 to its Schedule 13G, disclosing a 2.1% passive beneficial ownership stake in Cardlytics, Inc. as of June 30, 2025.